Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 137211-64-4 | MDL No. : | MFCD22666360 |
Formula : | C14H18ClN3O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | ARFCANNJTSJXLS-UHFFFAOYSA-N |
M.W : | 295.76 | Pubchem ID : | 53657990 |
Synonyms : |
|
Num. heavy atoms : | 20 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.5 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 3.0 |
Molar Refractivity : | 82.03 |
TPSA : | 76.38 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | Yes |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | Yes |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.2 cm/s |
Log Po/w (iLOGP) : | 2.16 |
Log Po/w (XLOGP3) : | 1.28 |
Log Po/w (WLOGP) : | 0.97 |
Log Po/w (MLOGP) : | 1.36 |
Log Po/w (SILICOS-IT) : | 2.19 |
Consensus Log Po/w : | 1.59 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.5 |
Solubility : | 0.926 mg/ml ; 0.00313 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.48 |
Solubility : | 0.972 mg/ml ; 0.00329 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -4.15 |
Solubility : | 0.0211 mg/ml ; 0.0000713 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 2.5 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
31 g | With triethylamine; potassium iodide In N,N-dimethyl-formamide at 90 - 95℃; | 4-Amino-5-chloro-2,3-dihydro-N-(4-piperidinyl)-7-benzomrancarboxamide (30 g), triethyl amine (30 ml), l-chloro-3-methoxy-propane (13.8 g) and potassium iodide (4 g) in dimethylformamide (150 ml) were taken into a reaction flask at 25-30°C. The resulting mixture was heated to 90-95°C and then maintained for 4-5 hours at the same temperature. The reaction mass was cooled to 25-30°C, followed by the addition of l-chloro-3- methoxy-propane (5 g) and triethylamine (10 ml) at the same temperature. The reaction mass was heated to 90-95°C and then maintained for 4-5 hours at the same temperature. After completion of reaction, the reaction mass was cooled to 25-30°C, followed by the addition of water (750 ml) and then extracting with dichloromethane (300 ml x 3 times). The layers were separated and the organic layer was washed with water (500 ml). Activated carbon powder (3 g) was added to the organic layer and then stirred for 10 minutes at 25-30°C, followed by filtration through carbon bed. The resulting filtrate was concentrated under vacuum to obtain a residue. To the resulting residue, water (350 ml) was added and then stirred for 30 minutes at 20-25°C. The solid separated was filtered and washed with water (50 ml x 2 times) to produce 31 g of Prucalopride monohydrate (Purity by HPLC: 97.0percent). |
[ 182808-16-8 ]
4-Amino-5-chloro-2,3-dihydrobenzofuran-7-carboxamide
Similarity: 0.84
[ 221180-26-3 ]
4-Amino-5-chloro-2-methoxy-N-((3S,4R)-3-methoxypiperidin-4-yl)benzamide hydrochloride
Similarity: 0.82
[ 220032-26-8 ]
4-Amino-5-chloro-2-methoxy-N-(piperidin-4-ylmethyl)benzamide
Similarity: 0.80
[ 654084-41-0 ]
4-Amino-5-chloro-2-methoxy-N-(piperidin-4-ylmethyl)benzamide hydrochloride
Similarity: 0.80
[ 1020055-26-8 ]
N-(3-Amino-4-chlorophenyl)-2-(hexyloxy)benzamide
Similarity: 0.76
[ 182808-16-8 ]
4-Amino-5-chloro-2,3-dihydrobenzofuran-7-carboxamide
Similarity: 0.84
[ 221180-26-3 ]
4-Amino-5-chloro-2-methoxy-N-((3S,4R)-3-methoxypiperidin-4-yl)benzamide hydrochloride
Similarity: 0.82
[ 220032-26-8 ]
4-Amino-5-chloro-2-methoxy-N-(piperidin-4-ylmethyl)benzamide
Similarity: 0.80
[ 654084-41-0 ]
4-Amino-5-chloro-2-methoxy-N-(piperidin-4-ylmethyl)benzamide hydrochloride
Similarity: 0.80
[ 1020055-26-8 ]
N-(3-Amino-4-chlorophenyl)-2-(hexyloxy)benzamide
Similarity: 0.76
[ 182808-16-8 ]
4-Amino-5-chloro-2,3-dihydrobenzofuran-7-carboxamide
Similarity: 0.84
[ 221180-26-3 ]
4-Amino-5-chloro-2-methoxy-N-((3S,4R)-3-methoxypiperidin-4-yl)benzamide hydrochloride
Similarity: 0.82
[ 220032-26-8 ]
4-Amino-5-chloro-2-methoxy-N-(piperidin-4-ylmethyl)benzamide
Similarity: 0.80
[ 654084-41-0 ]
4-Amino-5-chloro-2-methoxy-N-(piperidin-4-ylmethyl)benzamide hydrochloride
Similarity: 0.80
[ 1020055-26-8 ]
N-(3-Amino-4-chlorophenyl)-2-(hexyloxy)benzamide
Similarity: 0.76
[ 221180-26-3 ]
4-Amino-5-chloro-2-methoxy-N-((3S,4R)-3-methoxypiperidin-4-yl)benzamide hydrochloride
Similarity: 0.82
[ 220032-26-8 ]
4-Amino-5-chloro-2-methoxy-N-(piperidin-4-ylmethyl)benzamide
Similarity: 0.80
[ 654084-41-0 ]
4-Amino-5-chloro-2-methoxy-N-(piperidin-4-ylmethyl)benzamide hydrochloride
Similarity: 0.80
[ 1353980-67-2 ]
N-(Piperidin-4-yl)-2,3-dihydrobenzo[b][1,4]dioxine-5-carboxamide hydrochloride
Similarity: 0.72
[ 902837-04-1 ]
N-Isopropyl-2-(piperidin-4-yloxy)benzamide
Similarity: 0.72
[ 182808-16-8 ]
4-Amino-5-chloro-2,3-dihydrobenzofuran-7-carboxamide
Similarity: 0.84
[ 143878-29-9 ]
Methyl 4-acetamido-5-chloro-2,3-dihydrobenzofuran-7-carboxylate
Similarity: 0.75
[ 123654-26-2 ]
4-Amino-5-chloro-2,3-dihydrobenzofuran-7-carboxylic acid
Similarity: 0.73